An Evaluation of Albumin Microparticles for Pulmonary Drug Delivery

An Evaluation of Albumin Microparticles for Pulmonary Drug Delivery
Author :
Publisher :
Total Pages : 510
Release :
ISBN-10 : OCLC:222742507
ISBN-13 :
Rating : 4/5 ( Downloads)

Book Synopsis An Evaluation of Albumin Microparticles for Pulmonary Drug Delivery by : Mehdi Haghpanah

Download or read book An Evaluation of Albumin Microparticles for Pulmonary Drug Delivery written by Mehdi Haghpanah and published by . This book was released on 1997 with total page 510 pages. Available in PDF, EPUB and Kindle. Book excerpt:


An Evaluation of Albumin Microparticles for Pulmonary Drug Delivery Related Books

An Evaluation of Albumin Microparticles for Pulmonary Drug Delivery
Language: en
Pages: 510
Authors: Mehdi Haghpanah
Categories:
Type: BOOK - Published: 1997 - Publisher:

DOWNLOAD EBOOK

Evaluation of Albumin Microspheres as Delivery Systems for Proteins Drugs Vaccines
Language: en
Pages: 494
Authors: George Kwame Yeboah
Categories: Microencapsulation
Type: BOOK - Published: 2007 - Publisher:

DOWNLOAD EBOOK

Silk-based Drug Delivery Systems
Language: en
Pages: 243
Authors: Elia Bari
Categories: Science
Type: BOOK - Published: 2020-10-07 - Publisher: Royal Society of Chemistry

DOWNLOAD EBOOK

Covering spider silk and silk worm cocoons, the editors elucidate the extraction, structure and properties of silk sericin and silk fibroin.
Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems
Language: en
Pages: 620
Authors: Kamal Dua
Categories: Technology & Engineering
Type: BOOK - Published: 2020-08-04 - Publisher: Academic Press

DOWNLOAD EBOOK

Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems explores the development of novel therapeutics and diagnostics to improve pulm
Controlled Pulmonary Drug Delivery
Language: en
Pages: 560
Authors: Hugh D.C. Smyth
Categories: Medical
Type: BOOK - Published: 2011-06-24 - Publisher: Springer Science & Business Media

DOWNLOAD EBOOK

The pace of new research and level of innovation repeatedly introduced into the field of drug delivery to the lung is surprising given its state of maturity sin